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Abstract
Background: Many studies have found socioeconomic differentials in cancer survival. Previous
studies have generally demonstrated poorer cancer survival with decreasing socioeconomic status
but mostly used only ecological measures of status and analytical methods estimating simple
survival. This study investigate socio-economic differentials in cancer survival using four indicators
of socioeconomic status; three individual and one ecological. It uses a relative survival method
which gives a measure of excess mortality due to cancer.
Methods: This study uses prospective record linkage data from The Office for National Statistics
Longitudinal Study for England and Wales. The participants are Longitudinal Study members,
recorded at census in 1971 and 1981 and with a primary malignant cancer diagnosed at age 45 or
above, between 1981 and 1997, with follow-up until end 2000. The outcome measure is relative
survival/excess mortality, compared with age and sex adjusted survival of the general population.
Relative survival and Poisson regression analyses are presented, giving models of relative excess
mortality, adjusted for covariates.
Results: Different socioeconomic indicators detect survival differentials of varying magnitude and
definition. For all cancers combined, the four indicators show similar effects. For individual cancers
there are differences between indicators. Where there is an association, all indicators show poorer
survival with lower socioeconomic status.
Conclusion: Cancer survival differs markedly by socio-economic status. The commonly used
ecological measure, the Carstairs Index, is adequate at demonstrating socioeconomic differentials
in survival for combined cancers and some individual cancers. A combination of car access and
housing tenure is more sensitive than the ecological Carstairs measure at detecting socioeconomic
effects on survival – confirming Carstairs effects where they occur but additionally identifying
effects for other cancers. Social class is a relatively weak indicator of survival differentials.
Background
The objective of this study is to investigate socio-eco-
nomic differentials in cancer survival in England and
Wales using four indicators of socioeconomic status; three
individual and one ecological. Previous studies have gen-
erally demonstrated poorer cancer survival with decreas-
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ing socioeconomic status but often used only ecological
measures of status, or less extensive analytical methods.
Most recent work on cancer survival in England and Wales
has used patient data from cancer registries, which are
considered of good quality and near-complete coverage. A
major reference work on cancer survival, Cancer Survival
Trends (CST) in England and Wales: 1971 – 1995, was
published in 1999[1]. This work was detailed and com-
prehensive in its coverage of survival and a finding of con-
siderable policy importance was a gradient in survival
across levels of disadvantage for many cancers. An ecolog-
ical indicator of disadvantage, the Carstairs index, was
used because cancer registry data has poor or non-existent
recording of individual socioeconomic or sociodemo-
graphic variables. An analogous study for Scotland
showed similar results[2].
The Carstairs index is a composite score of levels of disad-
vantage in a defined geographic area, as measured by four
components: male unemployment, overcrowded house-
holds, household car access, low social class of heads of
households[3]. Although such measures have known lim-
itations they have nevertheless proved extremely useful
where individual level data are lacking[1,2,4-8].
The Office for National Statistics Longitudinal Study
(ONS LS) provides an opportunity to investigate socio-
economic differences in survival using variables measured
at the individual level. The LS is a record linkage study
providing census information, cancer registration and
death registration data for an effectively random 1% sam-
ple of the population of England and Wales (the sample
members). The original sample was drawn from people
enumerated in the 1971 Census and has been maintained
through the addition of 1% of immigrants and new births
and so remains nationally representative. Information
from later censuses was added as it became available. Trac-
ing of events such as cancer registration and death is
achieved via the National Health Services Central Register.
Details of tracing and linkage rates, which are high, have
been reported elsewhere[9].
The LS is limited by being a 1% sample, but has a major
advantage over cancer registry data because of the availa-
bility of individual socioeconomic and sociodemographic
information. Previous cancer survival/mortality studies
have used the LS but have been less extensive than the
present study and have not made use of relative survival
models[10-12].
The use of relative survival for cancer studies is now well
established[13]. The term implies survival of cancer
patients relative to survival expected from age and sex
matched rates for the general population. Where cause of
death registration is accurate and complete cancer survival
may be estimated directly by censoring non-cancer deaths
in the analysis; results are often very similar to the relative
survival approach. However, relative survival is consid-
ered more suitable because it calculates excess mortality
following a diagnosis of cancer, even if direct cause of
death is not cancer. This is more realistic for the many
cases where cancer, or its treatment, is debilitating and
causes death by the generation or worsening of other mor-
bidities. Multivariate models of relative survival have been
described and used in other studies, but not widely: per-
haps due to their perceived complexity and the fact that
some software cannot accommodate them[6,14-16].
Methods
This study did not require full ethical approval as it com-
prises secondary analysis of established anonymised data.
It was however approved by the Longitudinal Study
Research Board of the Office for National Statistics.
The study sample selected comprised LS members with a
first diagnosis of a primary malignant cancer at age 45
years or above, between 1981 and 1997. Additionally,
those included in the analysis had to have been present at
both the 1971 and 1981 Censuses. Registrations with a
date of death on the same day as diagnosis (8.75% over-
all) were excluded as these are known to be mostly "death
certificate only" diagnoses and are not usually included in
survival analysis. In cases of multiple or synchronous reg-
istrations only the first occurring registration matching
these criteria was selected.
Date of diagnosis and exit from the study were recorded.
Date of exit was the earliest date of either death, emigra-
tion or end of study (31 December 2000). Dates were
recorded to the day, thus giving survival durations in days.
Classification of cancer types followed the scheme pre-
sented in CST, updated where necessary for ICD-10. In
this study "All cancers" refer to any registered primary
malignancy, excluding non-melanoma skin cancer.
For modeling of relative survival individual records were
split into survival segments each of a single year of follow-
up. Up to five segments were used for each individual. The
splitting of records allowed the correct updating of time-
varying covariates such as age-group. Age-groups were:
45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80+.
The technique is described in detail elsewhere[16].
Calendar periods of diagnosis, or follow-up, were
matched with general population mortality schedules for
the calculation of relative survival. Population life tables
were those published for 1980–82 and for 1990–92 for
England and Wales, together with an inter-censal schedule
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centred on 1996 provided by the U.K. Government Actu-
aries Department[17]. The lifetables were therefore effec-
tively centred on 1981, 1991 and 1996 and the relevant
population risk of death, by age and sex, was matched
with each survival segment depending on calendar period
of survival: 1981–85, 1986–94,1995–2000 respectively.
Modeling of relative survival was conducted using Pois-
son regression of the counts of deaths, using a log offset of
person-years at risk, for single years following diagnosis. A
user-defined link function provided numbers of expected
deaths, calculated from population life table risks, ena-
bling rates relative to general population mortality to be
modeled (i.e. rate ratios for relative excess mortality due to
cancer)[14]. Because excess mortality is not constant by
age it remains necessary to include adjustment for age in
the regression models.
Socioeconomic differentials in survival were analysed
using four indicators of socio-economic status available
from the Census. These were, Registrar General's Social
Class; housing tenure; household access to a car and the
Carstairs indicator of relative area deprivation. Variables
were those recorded at the census before diagnosis. Social
class was unclassified for nearly a third of individuals,
mostly women. In models where social class was the only
socioeconomic variable it was used in an ordinal form
and missing values were, of necessity, excluded. For mod-
els where social class is included with other socioeco-
nomic variables as a control it was used in a categorical
form such that missing values are retained as a separate
category. For other socioeconomic indicators levels of
missing values are much lower, at around 2%.
Socioeconomic variables are categorised in Table 1.
Additionally we included an indicator of geographic loca-
tion at census. We first investigated using government
region, this showed a simplified indicator of north/south
zone was sufficient and this was used for simplicity. This
splits England and Wales along a line extending from the
Severn estuary to The Wash.
Analysis was performed using the statistical package Stata.
Point estimates of crude and relative survival were made
using the Stata strel routine derived for the CST study[1].
Results
Rate ratios for relative excess mortality by different indica-
tors of disadvantage are shown in Table 2. Model 1 gives
rate ratios for the disadvantage indicator controlled for
year of follow-up, age group, sex (where appropriate),
period of diagnosis and north/south geographic zone.
Model 2 additionally controls for other socioeconomic
indicators shown in the table.
Table 2 demonstrates strong effects for all socioeconomic
indicators, for all cancers combined. This finding persists
in separate sex models.
For individual cancers there is a consistent suggestion,
indicated by rate ratios greater than unity, of poorer sur-
vival with increasing disadvantage. This finding is not
always confirmed statistically but for some sites (i.e.
oesophagus) the consistency of raised rate ratios across
indicators suggests that socioeconomic effects on mortal-
ity may be better confirmed in studies of higher power.
There are certainly differences between the extent of differ-
entials identified. For individual cancers, Social Class is
statistically weak. This may be because many individuals,
mostly women, are unclassified by this scheme and there-
fore excluded from models where social class is the only
socioeconomic indicator used; the analysis therefore has
less power and may be subject to bias. The ecological Car-
stairs indicator is more powerful, confirming a socioeco-
nomic gradient for cancer of the lung, breast and bladder.
The Car Access indicator shows a socioeconomic differen-
tial for five cancers: lung, colorectal, bladder, cervix/uterus
and ovary, but not breast. Tenure shows a socioeconomic
differential for six cancers: lung, colorectal, breast, blad-
der, leukaemia, ovary. Only for lung cancer is a differen-
tial confirmed by every indicator.
For combined cancers, the different socioeconomic indi-
cators retain their significance in models including the
Table 1: Categorisation of socioeconomic variables.
Socioeconomic variable Categorisation Comparison
Social Class Registrar General's Social Class coded 1–6 for classes I-V respectively.
All other values considered missing in models of social class as only s/
e variable (column 1 of Table 2) and as a separate "other" category in 
other models.
Rate ratio per unit change in 6-point scale (professional to unskilled).
Carstairs quintiles Carstairs index for wards of E&W.
All residents of ward assigned quintile based on ward ranking.
Rate ratio per unit change in 5-point scale (less to more disadvantage).
Car Access Access to car or van by household. No car access vs any access.
Housing Tenure Owner-occupation or rented accommodation Rent vs own/occ.
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other socioeconomic indicators (Model 2), with the sole
exception of Social Class in the female model. In individ-
ual site models the Carstairs indicator retains its signifi-
cance for lung and breast. For bladder, cervix/uterus and
ovary the Carstairs indicator loses its significance whereas
the Car Access indicator does not.
Survival differentials are particularly strong for bladder
cancer. For cancer of ovary and cervix/uterus car access
suggests a strong socioeconomic differential, even though
this is not supported by other indicators. Table 3 summa-
rises these findings.
To test the gender specificity of the indicators for separate
cancers interaction terms were fitted. Few interactions
were significant (likelihood ratio test) and no clear pat-
tern of results was apparent. Interactions by period of
diagnosis, investigating possible changes in sensitivity of
indicators, were also inconclusive.
Discussion
Different socioeconomic indicators detect survival differ-
entials of varying magnitude and definition. For all can-
cers combined, the four indicators show similar effects.
For individual cancers there are differences between indi-
Table 2: Rate ratio, with 95% Confidence Interval, for excess mortality by socioeconomic indicator.
Cancer Social Class Model Carstairs Score Model Car Access Model Tenure Model
All cancers†
N = 26,273
1 1.11 1.09–1.14 1.12 1.10–1.14 1.41 1.34–1.49 1.45 1.38–1.52
2 1.05 1.02–1.08 1.06 1.04–1.08 1.19 1.13–1.26 1.26 1.20–1.33
All cancers, Male
N = 13,523
1 1.11 1.08–1.14 1.11 1.09–1.14 1.45 1.35–1.55 1.44 1.34–1.53
2 1.05 1.02–1.08 1.05 1.03–1.08 1.22 1.13–1.32 1.24 1.16–1.34
All cancers, Female
N = 12,750
1 1.10 1.06–1.15 1.12 1.09–1.15 1.34 1.24–1.46 1.42 1.33–1.53
2 1.04 0.99–1.09 1.07 1.04–1.10 1.14 1.05–1.24 1.27 1.17–1.37
Lung
N = 4,271
1 1.04 1.01–1.08 1.06 1.03–1.09 1.13 1.05–1.22 1.11 1.03–1.19
2 1.02 0.99–1.06 1.04 1.01–1.08 1.07 0.98–1.17 1.04 0.95–1.12
Oesophagus
N = 608
1 1.12 1.01–1.24 1.07 0.99–1.16 1.21 0.96–1.51 1.14 0.91–1.42
2 1.11 0.99–1.23 1.06 0.98–1.15 1.10 0.86–1.41 1.06 0.84–1.33
Stomach
N = 1,283
1 0.99 0.92–1.06 1.03 0.97–1.09 1.13 0.96–1.34 1.04 0.89–1.22
2 0.99 0.90–1.05 1.02 0.96–1.09 1.11 0.93–1.33 0.99 0.83–1.17
Colorectal
N = 3,298
1 1.01 0.94–1.08 1.01 0.96–1.07 1.25 1.08–1.46 1.15 1.00–1.32
2 0.98 0.91–1.06 0.99 0.94–1.04 1.24 1.05–1.46 1.08 0.93–1.26
Female Breast
N = 3,102
1 0.94 0.84–1.05 1.14 1.06–1.22 1.13 0.91–1.40 1.28 1.06–1.55
2 0.90 0.80–1.01 1.13 1.05–1.22 0.97 0.77–1.21 1.17 0.95–1.45
Bladder
N = 1,407
1 1.10 0.93–1.30 1.22 1.06–1.40 2.30 1.52–3.48 2.01 1.41–2.87
2 0.95 0.79–1.15 1.14 0.98–1.32 1.87 1.22–2.88 1.67 1.16–2.42
Prostate
N = 1,714
1 1.02 0.92–1.14 1.09 0.99–1.20 1.25 0.94–1.67 1.14 0.86–1.51
2 0.99 0.88–1.11 1.07 0.97–1.18 1.14 0.83–1.57 1.02 0.76–1.38
Pancreas
N = 641
1 1.09 0.99–1.21 1.02 0.94–1.09 1.06 0.85–1.33 1.13 0.91–1.41
2 1.08 0.98–1.20 1.01 0.93–1.09 0.97 0.75–1.25 1.11 0.87–1.42
Leukaemia
N = 446
1 1.07 0.87–1.32 1.09 0.95–1.24 1.25 0.80–1.96 1.58 1.08–2.32
2 1.05 0.84–1.31 1.05 0.91–1.21 1.08 0.68–1.71 1.42 0.93–2.17
Cervix/Uterus
N = 816
1 0.96 0.76–1.20 1.12 0.97–1.30 1.91 1.29–2.81 1.23 0.85–1.78
2 0.95 0.75–1.21 1.08 0.92–1.26 1.98 1.24–3.14 0.85 0.55–1.32
Ovary
N = 574
1 1.11 0.98–1.26 1.04 0.96–1.14 1.59 1.23–2.05 1.34 1.05–1.71
2 1.03 0.90–1.18 0.99 0.91–1.09 1.50 1.14–1.97 1.21 0.93–1.57
Social Class model: Registrar-General's Social Class – six point scale.
Carstairs model: quintiles of Carstairs index – five point scale.
Car Access model: binary indicator of no household access to car/van.
Tenure model: binary indicator of renting accommodation.
Model 1: Socioeconomic indicator controlled for year of follow-up, age group, sex (where appropriate), period of diagnosis, marital status, north/
south geographic zone.
Model 2: Model 1, additionally controlled for all other socioeconomic indicators shown.
Results in bold type significant at 5% level or below.
† any malignancy, not restricted to groups listed below 
Source: ONS Longitudinal Study
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cators. But where there is an association, all indicators
show poorer survival with lower socioeconomic status.
Many studies have demonstrated associations between
socioeconomic indicators and mortality or survival fol-
lowing a cancer diagnosis, although others have inconclu-
sive results[18].
Kogevinas et al, using the LS, found wide survival differen-
tials between housing tenure groups[10]. A later LS study
found rather weak effects of better survival among owner-
occupiers, compared to tenants, for younger subjects suf-
fering from breast, ovarian or prostate cancer.
Using data from the South Thames Cancer Registry, Schr-
ijvers et al investigated relative survival from ten common
cancers[6]. The Carstairs index was used as a proxy of soci-
oeconomic disadvantage. They found poorer survival with
increasing deprivation level of area for 7 out of the 10 can-
cers. Stomach, pancreas and ovarian cancer showed direc-
tionally similar gradients but these were weaker and
insignificant in controlled models.
The largest and most detailed study of cancer survival in
the UK to date is the CST study. Using the Carstairs index,
it showed improved survival among those living in less-
deprived areas. However, this was only confirmed statisti-
cally for 21 cancers[1]. Despite its size and comprehensive
scope the CST study did not employ multivariate meth-
ods, indeed only some results were age-standardised. The
Scottish study was more modest in scope but did test sur-
vival by age and sex controlled Cox models[2]. This also
used the Carstairs score as a socio-economic indicator and
gradients were found for many cancers.
McDavid et al conducted one of the few studies to date
using controlled multivariate models of relative excess
mortality to investigate cancer survival[15]. Survival from
cancers of the breast, prostate, lung and colorectum in
Kentucky were all strongly associated with type of health
insurance held – itself related to socioeconomic status.
Greenwald et al suggested socioeconomic influence on
survival may have separate mechanisms of action – sur-
vival differentials for highly lethal cancers may be the
result of income differentials buying better care (in the
US), whereas for cancers of better prognosis education dif-
ferentials may affect disease progression[19]. Supporting
this, an investigation into cancer survival in Turin,
showed a strong positive relation between survival and
higher levels of education for some less lethal cancers
only[20].
Level of education is perhaps the missing socioeconomic
indicator in this study. The British census has made vari-
ous attempts to capture educational level in censuses and
the questions asked in the 2001 census are very promis-
ing. However questions in the 1981 and 1991 censuses
asked only about education after age 18. For the older
cohorts in this study, especially women, this is even less
useful than social class.
To our knowledge this is only the second application of
multivariate models of relative excess mortality (the com-
plement of relative survival) to British cancer data: previ-
ous studies using less sophisticated case fatality rates, Cox
regression models or even simpler statistics. In addition
our models are not only controlled for age and sex but
also for period of diagnosis and geographic zone.
The fact that lifetables are not easily available by socioeco-
nomic status and therefore national tables are used here
for estimating relative survival could theoretically over-
emphasise socioeconomic differentials. This effect,
though recognized, is likely to be small and is largely
obviated by socioeconomic controls in survival mod-
els[21]. Overall relative survival estimates obtained were
very similar to those presented by the CST study, which
did use specially constructed lifetables reflecting socioeco-
nomic gradients.
The finding that combined cancers show strong socioeco-
nomic gradients for survival is not quite as clear-cut as it
appears because it is confounded by the fact that many of
the cancers with higher incidence among the disadvan-
Table 3: Summary table showing strength of association of excess mortality with socioeconomic indicators.
Socioeconomic effects confirmed 
by more than one indicator
Socioeconomic effect apparent but displayed by one indicator only 
(indicator showing effect)
Socioeconomic effect suggested by 
simple rate ratio but not 
confirmed by controlled models
Bladder Cervix/Uterus (Car Access) Stomach
Female Breast All Leukaemias (Tenure) Pancreas
Lung Oesophagus (Social Class) Prostate
Ovary
Colorectal
Source: ONS Longitudinal Study
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taged are those that are rapidly lethal (lung, oesophagus).
Those that show slightly higher incidence in the more
advantaged (breast, prostate) have longer survival peri-
ods. In other words the "case mix" of combined cancers
varies with socioeconomic status and this affects survival.
All indicators suggest a socioeconomic gradient for lung
cancer. This gradient is small but well defined and is per-
haps an example of improved power of detection of such
small effects for a common cancer. For other individual
cancers there are differences between the indicators. Sur-
vival gradients by Social Class are generally not well
defined, probably due to the known problems of unclas-
sified individuals, especially older women.
The import of demonstrating survival differentials
between groups with rate ratios in the order of 1.04 (lung)
is questionable but is related to the speed of lethality of
the cancer and may well reflect only lead time differences.
For sites such as bladder and cervix/uterus, for which sur-
vival times can be lengthy, rate ratios approaching 2
between groups are substantial, important, and less likely
to be merely lead time bias.
The Carstairs score picks out bladder and breast cancer as
having a socioeconomic gradient for survival but only for
bladder cancer do the car access and tenure indicators
endorse this effect, showing a much stronger association
than the ecological indicator. The effect concurs with
recent findings for bladder cancer but may well have been
missed had only the Carstairs score been used[22]. Car
access and tenure detect an association for colorectal can-
cer. This is not particularly well defined but is not detected
by the Carstairs measure at all. This is unexpected since
the CST study found a noticeable gradient with Carstairs
quintile, although their deprivation results were not age-
standardised. However not all studies have found socioe-
conomic differentials in survival from this cancer and this
association may well vary by indicator used[23].
For prostate and cervix/uterus a gradient by Carstairs'
score of the local area is suggested in uncontrolled models
(not shown) but not confirmed in controlled models.
This suggests that at least some of the gradients identified
in the CST study might not have persisted after age/sex
adjustment. However the Scottish trends study does sug-
gest a socioeconomic gradient (measured using Carstairs
score) for age adjusted Cox models of prostate and cervix
(but not uterus).
Survival gradients in combined leukaemias are difficult to
demonstrate, probably because they are not a homoge-
nous group of diseases. The Scottish study does not con-
firm a survival gradient by Carstairs quintile for the
combined group but the larger CST study demonstrates a
large gradient for chronic lymphoid leukaemia but very
much smaller effects in other leukaemias.
The indicator with an interesting profile of results is car
access: an indicator that is widely used in social science
studies. It shows a socioeconomic differential for colorec-
tal cancer and quite strong effects for cervix/uterus and
ovary that are not shown by Carstairs quintile or particu-
larly well by tenure. The effect for ovarian cancer is partic-
ularly interesting as it seems to be a strong effect.
Although the Scottish and CST studies detect a significant
gradient by Carstairs quintile it is not strong. These differ-
ences suggest that some indicators are particularly sensi-
tive to differences in survival for particular cancers,
possibly the more lethal women's cancers, and may be
more useful in these cases.
Although there is undoubted correlation between the
indicators used here it may well be that the utility of dif-
ferent indicators is their ability to select rather different
social groupings. For instance no car access (in Britain)
may be selecting a relatively small, particularly deprived,
and possibly rural biased, group as well as the elderly.
It is tempting to explain socioeconomic differentials in
survival by the simple explanation that patients of lower
social class, or education, ignore symptoms and present
later for diagnosis. Some studies have found less compli-
ance with screening and more co-morbidity among cer-
tain groups, including the socially disadvantaged [24-29].
However in two studies using comprehensively controlled
multivariate methods, adjustment for stage at diagnosis
did nothing to change socioeconomic differentials[6,15].
Other studies have also failed to show definitive links
between deprivation and cancer stage or biology or
tumour size [23,26,27,30-32]. Therefore, although
delayed presentation must play a part, it is by no means a
complete explanation.
The fact that socioeconomic association with survival
appears to be specific for certain cancers does not endorse
any simplistic biological theory linking disease progres-
sion in general with poverty or disadvantage. In popula-
tions with largely equitable healthcare access this leaves
differential treatment, health status and co-morbidity,
coping and support strategies (embracing level of
income), and understanding of, and ability to influence,
disease progression (embracing educational level) as
explanatory mechanisms for differential survival by socio-
economic status.
Ways of measuring socioeconomic status are manifold
and their utility for older people is especially problem-
atic[33]. Nevertheless it is important to consider different
measures, especially when it is possible that the measures
BMC Cancer 2007, 7:20 http://www.biomedcentral.com/1471-2407/7/20
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most widely used in cancer studies – the ecological meas-
ures – may not be the most sensitive.
Conclusion
For all cancers combined four indicators of socioeco-
nomic status show similar effects but for individual can-
cers there are different associations between
socioeconomic indicators. Where there is an association
all indicators show poorer survival with lower socioeco-
nomic status.
Social class is a relatively weak indicator, not least because
many individuals, especially older women, are unclassi-
fied by this scheme. A combination of car access and
housing tenure seems more sensitive than the ecological
Carstairs measure at detecting socioeconomic differentials
in survival – confirming Carstairs effects where they occur
(lung, bladder) but additionally identifying effects for
cancers of the colorectum, cervix/uterus and ovary, and
for leukaemias. For ovarian cancer particularly, reported
in larger studies as having only a small socioeconomic
gradient when measured by ecological measures, car
access identifies a relatively strong socioeconomic effect
on survival.
There is no clear evidence of sex-specificity of any socioe-
conomic indicator, nor of a changing association with
period of diagnosis.
Researchers in the area of cancer survival should endeav-
our to collect individual or household level indicators of
socioeconomic status when analysing survival and be
aware that different indicators may be more specific for
different cancers.
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